Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › fluticasone

fluticasone

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of fluticasone

84 trials tracked of fluticasone: 56 in phase 3 or 4 and 9 with published results. The most-cited published study has 101 citations.

84Trials tracked
56Phase 3 & 4
0Recruiting
9With published results
Phase distribution
Phase 4 22 Phase 3 34 Phase 2 17 Phase 1 3 Other / NA 8
  1. Phase 3 Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device Completed · 101 cited
  2. Phase 3 Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease Completed · 57 cited
  3. Phase 3 A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Completed · 21 cited
  4. Phase 3 A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma Completed · 19 cited
  5. Phase 4 A Proof of Concept Study to Evaluate the Dose Response for the Systemic Benefit Risk Ratio of Inhaled Fluticasone Propionate in Chronic Obstructive Pulmonary Disease Completed · 15 cited
  6. Phase 3 ACTIV-6: COVID-19 Study of Repurposed Medications Completed · 5 cited
Show 44 more trials
  1. Phase 3 Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Completed · 5 cited
  2. Phase 3 Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety Completed · 3 cited
  3. Phase 4 Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year Completed · 2 cited
  4. Phase 4 Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD Completed
  5. Phase 4 Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids Completed
  6. Phase 4 A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise Completed
  7. Phase 4 Cardiovascular Function in COPD Patients Completed
  8. Phase 4 The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus Completed
  9. Phase 4 Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis Completed
  10. Phase 4 Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis) Completed
  11. Phase 4 A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic Dermatitis Completed
  12. Phase 4 Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen Completed
  13. Phase 4 The Effects of Montelukast on Smokers With Asthma Completed
  14. Phase 4 Vitamin D Plus Fluticasone Propionate Completed
  15. Phase 4 Study Of Allergic Rhinitis In Patients Who Also Have Asthma Completed
  16. Phase 4 SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults Completed
  17. Phase 4 The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial Completed
  18. Phase 4 MethaCholine Bronchoprovocation Study (MeCIS) Completed
  19. Phase 4 Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease Completed
  20. Phase 4 Intranasal Steroids and Oxymetazoline in Allergic Rhinitis Completed
  21. Phase 4 Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms Completed
  22. Phase 4 A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber Completed
  23. Phase 4 Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome Completed
  24. Phase 3 12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device Completed
  25. Phase 3 Fluticasone Nasal Spray Patient Preference Study Completed
  26. Phase 3 Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001) Completed
  27. Phase 3 Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler Completed
  28. Phase 3 Efficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video Completed
  29. Phase 3 ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone) Completed
  30. Phase 3 Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis Completed
  31. Phase 3 Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents Completed
  32. Phase 3 A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies Completed
  33. Phase 3 RELOVAIR® Lung Deflation Study Completed
  34. Phase 3 A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies Completed
  35. Phase 3 Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study Completed
  36. Phase 3 Asthma Exacerbation Study Completed
  37. Phase 3 Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101) Completed
  38. Phase 3 Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA) Completed
  39. Phase 3 Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents Completed
  40. Phase 3 Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911) Completed
  41. Phase 3 Assessment of Fluticasone Propionate on Ocular Allergy Symptoms Completed
  42. Phase 3 Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER) Completed
  43. Phase 3 A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512) Completed
  44. Phase 3 Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps Completed

Showing the 50 most-cited and recently-updated of 84 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.